Clinical Trial Update: The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone) [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating canagliflozin in combination with metformin and pioglitazone for type 2 diabetes; results have been posted after study completio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• INVOKANA (CANAGLIFLOZIN)
• PIOGLITAZONE (Pioglitazone)
• metformin (metformin)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2013-05-21